Inhaled Cisplatin for NSCLC: Facts and Results

Although we have new diagnostic tools for non-small cell lung cancer, diagnosis is still made in advanced stages of the disease. However, novel treatments are being introduced in the market and new ones are being developed. Targeted therapies and immunotherapy have brought about a bloom in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmidis, Christoforos, Sapalidis, Konstantinos, Zarogoulidis, Paul, Sardeli, Chrysanthi, Koulouris, Charilaos, Giannakidis, Dimitrios, Pavlidis, Efstathios, Katsaounis, Athanasios, Michalopoulos, Nikolaos, Mantalobas, Stylianos, Koimtzis, Georgios, Alexandrou, Vyron, Tsiouda, Theodora, Amaniti, Aikaterini, Kesisoglou, Issak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514814/
https://www.ncbi.nlm.nih.gov/pubmed/31022839
http://dx.doi.org/10.3390/ijms20082005
Descripción
Sumario:Although we have new diagnostic tools for non-small cell lung cancer, diagnosis is still made in advanced stages of the disease. However, novel treatments are being introduced in the market and new ones are being developed. Targeted therapies and immunotherapy have brought about a bloom in the treatment of non-small cell lung cancer. Still we have to find ways to administer drugs in a more efficient and safe method. In the current review, we will focus on the administration of inhaled cisplatin based on published data.

Ejemplares similares